Drreddys Laboratories reported 6.5B in EBIT for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Ani Pharmaceuticals ANIP:US $ -6638000 9.72M
Aphria Inc APH:CN C$ -95267000 48.54M
Aurora Cannabis Inc ACB:CN C$ -126834000 32.63M
Bayer BAYN:GR 1.64B 1.42B
Canopy Growth Corp WEED:CN -92682000 59.14M
Catalent CTLT:US $ 253.3M 60.4M
Cipla CIPLA:IN 10.85B 5.74B
Corcept Therapeutics CORT:US $ 31.94M 12.3M
Drreddys Laboratories RDY:US 6.5B 909M
Endo International Ordinary Shares ENDP:US $ 195.54M 19.6M
GlaxoSmithKline GSK:LN 1.96B 281M
Gw Pharmaceuticals GWPH:US -21027000 1.78M
Hikma Pharmaceutical HIK:LN 280M 2M
Horizon Pharma HZNP:US 213.77M 303.22M
JAZZ PHA JAZZ:US -69590000 231.71M
Lannett LCI:US $ -4934000 7.78M
Lonza Group LONN:SW 599M 271M
Novartis NOVN:VX 3.4B 415M
Pacira Pharmaceuticals PCRX:US $ 34.99M 13.68M
Phibro Animal Health PAHC:US $ 19.16M 974K
Prestige Brands PBH:US $ 91.34M 20.4M
Richter Gedeon RICHT:HB 36.29B 12.59B
Sun Pharmaceuticals SUNP:IN 22.38B 7.32B
Supernus Pharmaceuticals SUPN:US $ 34.11M 20.9M
Teva Pharmaceutical TEVA:IT 829M 35M